Literature DB >> 23296955

Origin and pathogenesis of B cell lymphomas.

Marc Seifert1, René Scholtysik, Ralf Küppers.   

Abstract

Immunoglobulin (Ig) gene remodeling by V(D)J recombination plays a central role in the generation of normal B cells, and somatic hypermutation and class switching of Ig genes are key processes during antigen-driven B cell differentiation. However, errors of these processes are involved in the development of B cell lymphomas. Ig locus-associated translocations of proto-oncogenes are a hallmark of many B cell malignancies. Additional transforming events include inactivating mutations in various tumor suppressor genes, and also latent infection of B cells with viruses, such as Epstein-Barr virus. Many B cell lymphomas require B cell antigen receptor expression, and in several instances chronic antigenic stimulation plays a role in sustaining tumor growth. Often, survival and proliferation signals provided by other cells in the microenvironment are a further critical factor in lymphoma development and pathophysiology. Many B cell malignancies derive from germinal center B cells, most likely because of the high proliferation rate of these cells and the high activity of mutagenic processes.

Entities:  

Mesh:

Year:  2013        PMID: 23296955     DOI: 10.1007/978-1-62703-269-8_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  21 in total

1.  Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.

Authors:  Italo Tempera; Alessandra De Leo; Andrew V Kossenkov; Matteo Cesaroni; Hui Song; Noor Dawany; Louise Showe; Fang Lu; Priyankara Wikramasinghe; Paul M Lieberman
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

Review 2.  Pathogenesis beyond the cancer clone(s) in multiple myeloma.

Authors:  Giada Bianchi; Nikhil C Munshi
Journal:  Blood       Date:  2015-04-02       Impact factor: 22.113

Review 3.  The tumor microenvironment shapes hallmarks of mature B-cell malignancies.

Authors:  K H Shain; W S Dalton; J Tao
Journal:  Oncogene       Date:  2015-02-02       Impact factor: 9.867

4.  MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas.

Authors:  Gabriella Aquino; Laura Marra; Monica Cantile; Annarosaria De Chiara; Giuseppina Liguori; Maria Pia Curcio; Rocco Sabatino; Giuseppe Pannone; Antonio Pinto; Gerardo Botti; Renato Franco
Journal:  Infect Agent Cancer       Date:  2013-09-30       Impact factor: 2.965

5.  Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.

Authors:  Ryan Incrocci; Samira Hussain; Amanda Stone; Kathryn Bieging; Lauren A C Alt; Michael J Fay; Michelle Swanson-Mungerson
Journal:  Cell Immunol       Date:  2015-08-04       Impact factor: 4.868

6.  Monoclonal IgG in MGUS and multiple myeloma targets infectious pathogens.

Authors:  Adrien Bosseboeuf; Delphine Feron; Anne Tallet; Cédric Rossi; Cathy Charlier; Laurent Garderet; Denis Caillot; Philippe Moreau; Marina Cardó-Vila; Renata Pasqualini; Wadih Arap; Alfreda Destea Nelson; Bridget S Wilson; Hélène Perreault; Eric Piver; Pierre Weigel; François Girodon; Jean Harb; Edith Bigot-Corbel; Sylvie Hermouet
Journal:  JCI Insight       Date:  2017-10-05

7.  Case Report: Monoclonal Gammopathy of Undetermined Significance is Associated with Loa loa Infection.

Authors:  Derek B Laskar; Michael Rose; Raavi Gupta; Herbert B Tanowitz; M A Haseeb
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

8.  Biological and Clinical Implications of Clonal Heterogeneity and Clonal Evolution in Multiple Myeloma.

Authors:  Giada Bianchi; Irene M Ghobrial
Journal:  Curr Cancer Ther Rev       Date:  2014

9.  B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity.

Authors:  Jason Qian; Qiao Wang; Marei Dose; Nathanael Pruett; Kyong-Rim Kieffer-Kwon; Wolfgang Resch; Genqing Liang; Zhonghui Tang; Ewy Mathé; Christopher Benner; Wendy Dubois; Steevenson Nelson; Laura Vian; Thiago Y Oliveira; Mila Jankovic; Ofir Hakim; Anna Gazumyan; Rushad Pavri; Parirokh Awasthi; Bin Song; Geng Liu; Longyun Chen; Shida Zhu; Lionel Feigenbaum; Louis Staudt; Cornelis Murre; Yijun Ruan; Davide F Robbiani; Qiang Pan-Hammarström; Michel C Nussenzweig; Rafael Casellas
Journal:  Cell       Date:  2014-12-04       Impact factor: 41.582

Review 10.  Novel agents in the treatment of multiple myeloma: a review about the future.

Authors:  Leonard Naymagon; Maher Abdul-Hay
Journal:  J Hematol Oncol       Date:  2016-06-30       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.